These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23625407)

  • 21. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Bergquist J; Palmblad M; Wetterhall M; Håkansson P; Markides KE
    Mass Spectrom Rev; 2002; 21(1):2-15. PubMed ID: 12210611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE; Katz JE; Agus DB
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker discovery: tissues versus fluids versus both.
    Johann DJ; Blonder J
    Expert Rev Mol Diagn; 2007 Sep; 7(5):473-5. PubMed ID: 17892354
    [No Abstract]   [Full Text] [Related]  

  • 25. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M; Kalousis A
    Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidomics: identification of pathogenic and marker peptides.
    Xiang Y; Kurokawa MS; Kanke M; Takakuwa Y; Kato T
    Methods Mol Biol; 2010; 615():259-71. PubMed ID: 20013215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic technologies for prenatal diagnostics: advances and challenges ahead.
    Choolani M; Narasimhan K; Kolla V; Hahn S
    Expert Rev Proteomics; 2009 Feb; 6(1):87-101. PubMed ID: 19210129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ; Veenstra TD
    Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker discovery from body fluids using mass spectrometry.
    Villar-Garea A; Griese M; Imhof A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics of human seminal plasma: identification of biomarker candidates for fertility and infertility and the evolution of technology.
    Milardi D; Grande G; Vincenzoni F; Castagnola M; Marana R
    Mol Reprod Dev; 2013 May; 80(5):350-7. PubMed ID: 23559416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease.
    Yilmaz Y
    Clin Chim Acta; 2012 Aug; 413(15-16):1190-3. PubMed ID: 22546610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker discovery in transplantation--proteomic adventure or mission impossible?
    Kienzl-Wagner K; Pratschke J; Brandacher G
    Clin Biochem; 2013 Apr; 46(6):497-505. PubMed ID: 23089107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretome profiling with antibody microarrays.
    Mustafa SA; Hoheisel JD; Alhamdani MS
    Mol Biosyst; 2011 Jun; 7(6):1795-801. PubMed ID: 21505656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ion activation methods for tandem mass spectrometry.
    Sleno L; Volmer DA
    J Mass Spectrom; 2004 Oct; 39(10):1091-112. PubMed ID: 15481084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
    Christin C; Bischoff R; Horvatovich P
    Talanta; 2011 Jan; 83(4):1209-24. PubMed ID: 21215856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.